Patents Assigned to DREMCUBED, LLC
  • Nutraceutical formulation for unblocking receptors
    Patent number: 11219612
    Abstract: A nutraceutical formulation used to unblock receptors is disclosed herein. The nutraceutical formulation used to therapeutically treat humans includes arachidonic acid, docosahexaenoic acid (DHA), echinacea, kaempferol, coffee fruit, and probiotics.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: January 11, 2022
    Assignee: DREMCUBED, LLC
    Inventors: Amy Motil, Matt Motil